Dr. Hannele Yki-Järvinen, MD, FRCP, is Professor of Medicine at the Department of Medicine, University of Helsinki, Finland. She is a specialist in internal medicine and endocrinology. Her main academic interests are causes and consequences of insulin resistance in vivo in humans, especially non-alcoholic fatty liver disease (NAFLD), and application of this knowledge to treatment of type 2 diabetes. She has published over 300 original articles in English and over 50 reviews and written chapters to textbooks such as the International Textbook of Diabetes Mellitus, the Oxford Textbook of Endocrinology and Diabetes and the Textbook of Diabetes. She has received several international awards including the G. B. Morgagni Young Investigator Award, Padova, Italy, the 28th Minkowski Award, European Association for the Study of Diabetes, Istanbul, Turkey, the Anders Jahre Pris, University of Oslo, Oslo, Norway and Novartis Award in Diabetes for excellence in patient-oriented research in San Diego, USA. 2008. She has given many award lectures such as the 16th Servier Lecture in Manila, Philippines, the first Dr. Augusto D. Litonjua Endowed Lectureship, Manila, Philippines. In 2011, she gave received the Harold Rifkin Visiting Professorship at Albert Einstein College of Medicine, New York, USA. She is ranked as #578 out of 100 000 top scientists in the world on the Stanford list, (Ioannidis JPA & al. PLOS Biol 2019; 17 (8):e3000384. doi: 101371/journal.pbio.3000384)

Emerging Therapies for NASH

Mar 24, 2021 9:00am ‐ Mar 24, 2021 12:25pm

Co-Chair(s):